u-62840 and Hypertrophy

u-62840 has been researched along with Hypertrophy* in 1 studies

Other Studies

1 other study(ies) available for u-62840 and Hypertrophy

Article	Year
Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling. American journal of respiratory and critical care medicine, 2020, 05-15, Volume: 201, Issue:10 Topics: Animals; Antihypertensive Agents; Cell Proliferation; Cyclic AMP-Dependent Protein Kinases; Down-Regulation; Epoprostenol; Humans; Hypertrophy; Hypoxia; Immunosuppressive Agents; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Receptors, Immunologic; Receptors, Prostaglandin; RNA, Messenger; Sirolimus; Vascular Remodeling	2020

Article

Year

Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.

American journal of respiratory and critical care medicine, 2020, 05-15, Volume: 201, Issue:10

Topics: Animals; Antihypertensive Agents; Cell Proliferation; Cyclic AMP-Dependent Protein Kinases; Down-Regulation; Epoprostenol; Humans; Hypertrophy; Hypoxia; Immunosuppressive Agents; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Receptors, Immunologic; Receptors, Prostaglandin; RNA, Messenger; Sirolimus; Vascular Remodeling

2020